Founded in 2005, by Alexandre TOKAY, CEO, and Dr. Michel KHRESTCHATISKY, Scientific Advisor, VECT-HORUS is a spin-off of the NICN UMR7259 (CNRS and Aix-Marseille University) now Institute for NeuroPhysiopathology (INP) directed by Dr. Michel KHRESTCHATISKY (UMR7051, CNRS AMU). Based in Marseille, France, the company has 35 employees, mostly in R&D, under the responsibility of Dr. Jamal TEMSAMANI, Head of Drug Development.
Alexandre TOKAY
CEO and cofounder
Michel KHRESTCHATISKY
Co-founder and scientific counsel
Jamal TEMSAMANI
Drug Development and Corporate